vs
Esperion Therapeutics, Inc.（ESPR）与WD 40 CO（WDFC）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是WD 40 CO的1.1倍（$168.4M vs $154.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 0.6%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 5.4%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
WD-40公司是全球知名的消费及工业维护用品生产商，核心产品为同名多功能防锈润滑剂，同时布局清洁剂、除油剂、特殊润滑产品等品类，业务覆盖全球170余个国家和地区，服务零售、工业、汽车后市场等多个领域。
ESPR vs WDFC — 直观对比
营收规模更大
ESPR
是对方的1.1倍
$154.4M
营收增速更快
ESPR
高出143.1%
0.6%
两年增速更快
ESPR
近两年复合增速
5.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $154.4M |
| 净利润 | — | $17.5M |
| 毛利率 | — | 56.2% |
| 营业利润率 | 50.6% | 15.1% |
| 净利率 | — | 11.3% |
| 营收同比 | 143.7% | 0.6% |
| 净利润同比 | — | -7.8% |
| 每股收益（稀释后） | $0.32 | $1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRWDFC
| Q4 25 | $168.4M | $154.4M | ||
| Q3 25 | $87.3M | $163.5M | ||
| Q2 25 | $82.4M | $156.9M | ||
| Q1 25 | $65.0M | $146.1M | ||
| Q4 24 | $69.1M | $153.5M | ||
| Q3 24 | $51.6M | $156.0M | ||
| Q2 24 | $73.8M | $155.0M | ||
| Q1 24 | $137.7M | $139.1M |
净利润ESPRWDFC
| Q4 25 | — | $17.5M | ||
| Q3 25 | $-31.3M | $21.2M | ||
| Q2 25 | $-12.7M | $21.0M | ||
| Q1 25 | $-40.5M | $29.9M | ||
| Q4 24 | — | $18.9M | ||
| Q3 24 | $-29.5M | $16.8M | ||
| Q2 24 | $-61.9M | $19.8M | ||
| Q1 24 | $61.0M | $15.5M |
毛利率ESPRWDFC
| Q4 25 | — | 56.2% | ||
| Q3 25 | — | 54.7% | ||
| Q2 25 | — | 56.2% | ||
| Q1 25 | — | 54.6% | ||
| Q4 24 | — | 54.8% | ||
| Q3 24 | — | 54.1% | ||
| Q2 24 | — | 53.1% | ||
| Q1 24 | — | 52.4% |
营业利润率ESPRWDFC
| Q4 25 | 50.6% | 15.1% | ||
| Q3 25 | -11.4% | 17.1% | ||
| Q2 25 | 8.6% | 17.4% | ||
| Q1 25 | -34.0% | 15.9% | ||
| Q4 24 | -6.4% | 16.4% | ||
| Q3 24 | -31.0% | 15.4% | ||
| Q2 24 | 3.5% | 17.5% | ||
| Q1 24 | 52.5% | 15.1% |
净利率ESPRWDFC
| Q4 25 | — | 11.3% | ||
| Q3 25 | -35.9% | 13.0% | ||
| Q2 25 | -15.4% | 13.4% | ||
| Q1 25 | -62.2% | 20.4% | ||
| Q4 24 | — | 12.3% | ||
| Q3 24 | -57.2% | 10.8% | ||
| Q2 24 | -83.9% | 12.8% | ||
| Q1 24 | 44.3% | 11.2% |
每股收益（稀释后）ESPRWDFC
| Q4 25 | $0.32 | $1.28 | ||
| Q3 25 | $-0.16 | $1.57 | ||
| Q2 25 | $-0.06 | $1.54 | ||
| Q1 25 | $-0.21 | $2.19 | ||
| Q4 24 | $-0.14 | $1.39 | ||
| Q3 24 | $-0.15 | $1.23 | ||
| Q2 24 | $-0.33 | $1.46 | ||
| Q1 24 | $0.34 | $1.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $48.6M |
| 总债务越低越好 | — | $85.7M |
| 股东权益账面价值 | $-302.0M | $264.1M |
| 总资产 | $465.9M | $459.7M |
| 负债/权益比越低杠杆越低 | — | 0.32× |
8季度趋势，按日历期对齐
现金及短期投资ESPRWDFC
| Q4 25 | $167.9M | $48.6M | ||
| Q3 25 | $92.4M | $58.1M | ||
| Q2 25 | $86.1M | $51.7M | ||
| Q1 25 | $114.6M | $53.0M | ||
| Q4 24 | $144.8M | $54.9M | ||
| Q3 24 | $144.7M | $46.7M | ||
| Q2 24 | $189.3M | $45.3M | ||
| Q1 24 | $226.6M | $55.4M |
总债务ESPRWDFC
| Q4 25 | — | $85.7M | ||
| Q3 25 | — | $86.2M | ||
| Q2 25 | — | $85.6M | ||
| Q1 25 | — | $84.4M | ||
| Q4 24 | — | $84.6M | ||
| Q3 24 | — | $86.0M | ||
| Q2 24 | — | $85.5M | ||
| Q1 24 | — | $85.9M |
股东权益ESPRWDFC
| Q4 25 | $-302.0M | $264.1M | ||
| Q3 25 | $-451.4M | $268.2M | ||
| Q2 25 | $-433.5M | $257.1M | ||
| Q1 25 | $-426.2M | $242.1M | ||
| Q4 24 | $-388.7M | $226.3M | ||
| Q3 24 | $-370.2M | $230.5M | ||
| Q2 24 | $-344.2M | $222.2M | ||
| Q1 24 | $-294.3M | $216.3M |
总资产ESPRWDFC
| Q4 25 | $465.9M | $459.7M | ||
| Q3 25 | $364.0M | $475.8M | ||
| Q2 25 | $347.1M | $456.0M | ||
| Q1 25 | $324.0M | $458.3M | ||
| Q4 24 | $343.8M | $447.3M | ||
| Q3 24 | $314.1M | $449.0M | ||
| Q2 24 | $352.3M | $443.6M | ||
| Q1 24 | $373.1M | $442.0M |
负债/权益比ESPRWDFC
| Q4 25 | — | 0.32× | ||
| Q3 25 | — | 0.32× | ||
| Q2 25 | — | 0.33× | ||
| Q1 25 | — | 0.35× | ||
| Q4 24 | — | 0.37× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | — | 0.40× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $10.0M |
| 自由现金流经营现金流 - 资本支出 | — | $9.1M |
| 自由现金流率自由现金流/营收 | — | 5.9% |
| 资本支出强度资本支出/营收 | 0.0% | 0.6% |
| 现金转化率经营现金流/净利润 | — | 0.57× |
| 过去12个月自由现金流最近4个季度 | — | $78.2M |
8季度趋势，按日历期对齐
经营现金流ESPRWDFC
| Q4 25 | $45.2M | $10.0M | ||
| Q3 25 | $-4.3M | $29.9M | ||
| Q2 25 | $-31.4M | $35.1M | ||
| Q1 25 | $-22.6M | $8.0M | ||
| Q4 24 | $-35.0M | $14.9M | ||
| Q3 24 | $-35.3M | $27.2M | ||
| Q2 24 | $-7.2M | $19.9M | ||
| Q1 24 | $53.8M | $18.0M |
自由现金流ESPRWDFC
| Q4 25 | — | $9.1M | ||
| Q3 25 | — | $28.6M | ||
| Q2 25 | — | $34.0M | ||
| Q1 25 | — | $6.6M | ||
| Q4 24 | — | $14.2M | ||
| Q3 24 | $-35.5M | $26.4M | ||
| Q2 24 | $-7.3M | $18.7M | ||
| Q1 24 | $53.8M | $16.7M |
自由现金流率ESPRWDFC
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | 17.5% | ||
| Q2 25 | — | 21.6% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | 9.3% | ||
| Q3 24 | -68.7% | 16.9% | ||
| Q2 24 | -9.9% | 12.0% | ||
| Q1 24 | 39.0% | 12.0% |
资本支出强度ESPRWDFC
| Q4 25 | 0.0% | 0.6% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.0% | 0.9% | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.3% | 0.5% | ||
| Q2 24 | 0.1% | 0.8% | ||
| Q1 24 | 0.1% | 0.9% |
现金转化率ESPRWDFC
| Q4 25 | — | 0.57× | ||
| Q3 25 | — | 1.41× | ||
| Q2 25 | — | 1.67× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.79× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | 1.00× | ||
| Q1 24 | 0.88× | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
WDFC
| Other | $82.6M | 53% |
| WD40Multi Use Product | $56.0M | 36% |
| WD40Specialist | $9.0M | 6% |
| Other Maintenance Products | $4.0M | 3% |
| Homecare And Cleaning Products | $2.7M | 2% |
